RecruitingNot applicableNCT07171554

Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer

Studying Best vitelliform macular dystrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oncosyne AS
Principal Investigator
Anne H Ree, MD, Professor of Oncology
University Hospital, Akershus
Intervention
µCAN drug screen test(diagnostic_test)
Enrollment
75 target
Eligibility
18 years · All sexes
Timeline
2025 – 2029

Study locations (1)

Collaborators

University Hospital, Akershus · CTC Clinical Trial Consultants AB

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07171554 on ClinicalTrials.gov

Other trials for Best vitelliform macular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Best vitelliform macular dystrophy →

← Back to all trials